0000899243-17-028061.txt : 20171206 0000899243-17-028061.hdr.sgml : 20171206 20171206160527 ACCESSION NUMBER: 0000899243-17-028061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171205 FILED AS OF DATE: 20171206 DATE AS OF CHANGE: 20171206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Molineaux Christopher CENTRAL INDEX KEY: 0001618120 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36644 FILM NUMBER: 171242332 MAIL ADDRESS: STREET 1: CALITHERA BIOSCIENCES STREET 2: 343 OYSTER POINT, SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Calithera Biosciences, Inc. CENTRAL INDEX KEY: 0001496671 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272366329 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 343 OYSTER POINT BLVD #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-870-1000 MAIL ADDRESS: STREET 1: 343 OYSTER POINT BLVD #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-12-05 0 0001496671 Calithera Biosciences, Inc. CALA 0001618120 Molineaux Christopher C/O CALITHERA BIOSCIENCES, INC. 343 OYSTER POINT BLVD. #200 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 SR. VP, DEVELOPMENT Common Stock 2017-12-05 4 M 0 6502 0.96 A 9002 D Common Stock 2017-12-05 4 M 0 2700 2.64 A 11702 D Common Stock 349190 I By Trust Common Stock 15368 I By Spouse Employee Stock Option (Right to Buy) 0.96 2017-12-05 4 M 0 6502 0.00 D 2023-05-22 Common Stock 6502 0 D Employee Stock Option (Right to Buy) 2.64 2017-12-05 4 M 0 2700 0.00 D 2023-12-16 Common Stock 2700 6006 D Employee Stock Option (Right to Buy) 0.96 2017-12-05 4 M 0 7568 0.00 D 2023-05-22 Common Stock 7568 0 I By Spouse Employee Stock Option (Right to Buy) 2.64 2017-12-05 4 M 0 5300 0.00 D 2023-12-16 Common Stock 5300 34030 I By Spouse Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on June 9, 2017. Shares are held by the Molineaux Family Trust, of which the Reporting Person is a Trustee, including 12,044 shares transferred from the Reporting Person to the Molineaux Family Trust on March 30, 2017. 1/48 of the Option vests in equal monthly installments one month from 05/23/2013. The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company. 1/48 of the Option vests in equal monthly installments one month from 12/17/2013. The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company. /s/ Christopher J. Molineaux 2017-12-06